The impact of CYP2C19 genotype on phenoconversion by concomitant medication

被引：0
|
作者：
De Jong, Laura [1 ]
Boussallami, Soukayna [1 ]
Hawinkels, Luuk [4 ]
Hoekstra, Menno [1 ]
Tushuizen, Maarten [4 ]
Rissmann, Robert [3 ]
Swen, Jesse [2 ]
Manson, Martijn [1 ]
机构：
[1] Leiden Acad Ctr Drug Res, Div Syst Pharmacol & Pharm, Leiden, Netherlands
[2] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Ctr Human Drug Res, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Dept Gastroenterol Hepatol, Med Ctr, Leiden, Netherlands
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0547
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 50 条
  • [31] Phenoconversion Due to Drug-Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
    Abouir, Kenza
    Exquis, Nadia
    Gloor, Yvonne
    Daali, Youssef
    Samer, Caroline Flora
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 1121 - 1129
  • [32] Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status
    Furuta, T
    Shirai, N
    Sugimoto, M
    Nakamura, A
    Okudaira, K
    Kajimura, M
    Hishida, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (01) : 67 - 74
  • [33] The importance of CYP2C19 genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipients
    Huang, Xiao
    Zhou, Ying
    Zhang, Jing
    Xiang, Hongping
    Mei, Hao
    Liu, Li
    Tong, Lu
    Zeng, Fang
    Huang, Yifei
    Zhou, Hong
    Zhang, Yu
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (10) : 4515 - 4525
  • [34] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [35] Evaluation of a CYP2C19 genotype panel on the GenMark eSensor® platform and the comparison to the Autogenomics Infiniti™ and Luminex CYP2C19 panels
    Lee, Christine C.
    McMillin, Gwendolyn A.
    Babic, Nikolina
    Melis, Roberta
    Yeo, Kiang-Teck J.
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1133 - 1137
  • [36] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [37] A Study On The Impact Of CYP2C19 Genotype And Platelet Reactivity Assay On Patients Undergoing PCI
    Chidambaram, Sundar
    Rath, Prathap C.
    Dixit, Byomakesh
    Rath, Pallavi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B87 - B87
  • [38] Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
    Li, Zi-Wei
    Peng, Feng-Hua
    Yan, Miao
    Liang, Wu
    Liu, Xiao-Lei
    Wu, Yan-Qin
    Lin, Xiao-Bin
    Tan, Sheng-Lan
    Wang, Feng
    Xu, Ping
    Fang, Ping-Fei
    Liu, Yi-Ping
    Xiang, Da-Xiong
    Zhang, Bi-Kui
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 422 - 428
  • [39] Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine
    Green, Bruce
    Crauwels, Herta
    Kakuda, Thomas N.
    Vanveggel, Simon
    Brochot, Anne
    CLINICAL PHARMACOKINETICS, 2017, 56 (05) : 525 - 536
  • [40] Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine
    Bruce Green
    Herta Crauwels
    Thomas N. Kakuda
    Simon Vanveggel
    Anne Brochot
    Clinical Pharmacokinetics, 2017, 56 : 525 - 536
12345